![](/img/cover-not-exists.png)
A successful collaboration between academia, biotech and pharma led to discovery of erdafitinib, a selective FGFR inhibitor recently approved by the FDA
Murray, Christopher W., Newell, David R., Angibaud, PatrickYear:
2019
Language:
english
Journal:
MedChemComm
DOI:
10.1039/c9md90044f
File:
PDF, 952 KB
english, 2019